ALTUCCI, LUCIA
 Distribuzione geografica
Continente #
AS - Asia 1.148
NA - Nord America 725
EU - Europa 286
SA - Sud America 228
Continente sconosciuto - Info sul continente non disponibili 55
AF - Africa 20
OC - Oceania 1
Totale 2.463
Nazione #
US - Stati Uniti d'America 679
SG - Singapore 500
CN - Cina 259
BR - Brasile 186
VN - Vietnam 148
HK - Hong Kong 113
IT - Italia 89
FR - Francia 70
KR - Corea 37
DE - Germania 28
GB - Regno Unito 23
NL - Olanda 23
CA - Canada 19
AR - Argentina 18
FI - Finlandia 15
JP - Giappone 15
BD - Bangladesh 12
IN - India 10
MX - Messico 10
ZA - Sudafrica 10
VE - Venezuela 8
SA - Arabia Saudita 7
IL - Israele 6
TR - Turchia 6
IQ - Iraq 5
PY - Paraguay 5
RU - Federazione Russa 5
ID - Indonesia 4
TH - Thailandia 4
DZ - Algeria 3
EC - Ecuador 3
ES - Italia 3
GR - Grecia 3
HN - Honduras 3
IE - Irlanda 3
JM - Giamaica 3
PE - Perù 3
PK - Pakistan 3
SE - Svezia 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BO - Bolivia 2
CH - Svizzera 2
CO - Colombia 2
GT - Guatemala 2
KE - Kenya 2
LB - Libano 2
LV - Lettonia 2
NI - Nicaragua 2
NP - Nepal 2
PL - Polonia 2
PR - Porto Rico 2
RO - Romania 2
SI - Slovenia 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BM - Bermuda 1
CG - Congo 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GM - Gambi 1
IR - Iran 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
MA - Marocco 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
UZ - Uzbekistan 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.409
Città #
Singapore 293
Santa Clara 283
Hong Kong 113
Hefei 85
Beijing 79
Ashburn 77
San Jose 63
Ho Chi Minh City 62
Lauterbourg 60
Hanoi 36
Seoul 36
Los Angeles 29
Naples 18
New York 17
São Paulo 14
Dallas 12
Frankfurt am Main 12
Rome 11
Milan 10
Tokyo 8
Atlanta 7
Buffalo 7
Turku 7
Haiphong 6
Johannesburg 6
Nuremberg 6
Curitiba 5
Lappeenranta 5
Minamishinagawa 5
Rio de Janeiro 5
Bengaluru 4
Da Nang 4
Detroit 4
London 4
Montreal 4
Riyadh 4
Belo Horizonte 3
Brooklyn 3
Falkenstein 3
Fayetteville 3
Florence 3
Guangzhou 3
Helsinki 3
Houston 3
Marigliano 3
Mexico City 3
Munich 3
Philadelphia 3
Stockholm 3
Sumaré 3
São Carlos 3
São Vicente 3
Thessaloniki 3
Amsterdam 2
Aracaju 2
Araucária 2
Asunción 2
Aversa 2
Ballston Spa 2
Betim 2
Buenos Aires 2
Bắc Ninh 2
Bến Tre 2
Campinas 2
Can Tho 2
Chicago 2
Collinsville 2
Council Bluffs 2
Dalian 2
Denver 2
Dhaka 2
Duque de Caxias 2
Edmonton 2
Egg Harbor Township 2
El Cajon 2
Franca 2
Fullerton 2
Governador Valadares 2
Guarujá 2
Guarulhos 2
Guatemala City 2
Hải Dương 2
Istanbul 2
Jacksonville 2
João Pessoa 2
Kathmandu 2
Las Vegas 2
Lexington 2
León 2
Lima 2
Ljubljana 2
Mableton 2
Managua 2
Manchester 2
Miami 2
Montréal-Nord 2
Moscow 2
Nairobi 2
Orem 2
Osaka 2
Totale 1.546
Nome #
A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer 86
miR-194-5p/BCLAF1 deregulation in AML tumorigenesis. 66
Combating Actions of Green 2D-Materials on Gram Positive and Negative Bacteria and Enveloped Viruses 63
Biological activities of root extract of the purple carrot (Daucus carota L.) cv. 'Purple Sun' 63
Anticancer activities of anthocyanin extract from genotyped Solanum tuberosum L. "Vitelotte" 60
Single-Cell Photothermal Analysis Induced by MoS2 Nanoparticles by Raman Spectroscopy 59
HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or b. 57
D-ribose-glycation of insulin prevents amyloid aggregation and produces cytotoxic adducts 55
Looking beyond the glioblastoma mask: is genomics the right path? 55
Trifolium Repens Blocks Proliferation in Chronic Myelogenous Leukemia via the BCR-ABL/STAT5 Pathway 55
A DNA Methyltransferase Modulator Inspired by Peyssonenyne Natural Product Structures. 53
Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies 52
Secretome profiling of cytokines and growth factors reveals that neuro-glial differentiation is associated with the down-regulation of Chemokine Ligand 2 (MCP-1/CCL2) in amniotic fluid derived-mesenchymal progenitor cells. 52
"Stockpile" of slight transcriptomic changes determines the indirect genotoxicity of low-dose BPA in thyroid cells 52
Carprofen analogues as sirtuin inhibitors: enzyme and cellular studies. 51
Nonlinear protein - nucleic acid crosslinking induced by femtosecond UV laser pulses in living cells 49
1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondrial Function and Exhibit Inhibition of Proliferation in Cancer Cells. 48
The class I-specific HDAC inhibitor MS-275 modulates the differentiation potential of mouse embryonic stem cells. 48
Sirtuin functions and modulation: from chemistry to the clinic 47
ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias 46
Epigenetic alterations in glioblastomas: diagnostic, prognostic and therapeutic relevance 44
c-Myc modulation & acetylation is a key HDAC inhibitor target in cancer 44
The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs. 42
MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat 41
Structure-Activity Relationships on Cinnamoyl Derivatives as Inhibitors of p300 Histone Acetyltransferase 37
Antiproliferative, antibacterial and antifungal activity of the lichen Xanthoria parietina and its secondary metabolite parietin 36
Evaluation of a large library of (thiazol-2-yl)hydrazones and analogues as histone acetyltransferase inhibitors: Enzyme and cellular studies 36
Trials with 'epigenetic' drugs: An update. 33
miRNA-mediated deregulation in leukemia 32
Targeting epigenetic networks with polypharmacology: a new avenue to tackle cancer 32
Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine-Specific Demethylases Display High Anticancer Activities 31
Histone deacetylase inhibitors: a patent review (2009 - 2011). 31
Discovery of Salermide-Related Sirtuin Inhibitors: Binding Mode Studies and Antiproliferative Effects in Cancer Cells Including Cancer Stem Cells 31
Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cells. 31
Functions, Aberrations, and Advances for Chromatin Modulation in Cancer 31
Antioxidant, antimicrobial and anti-proliferative activities of Solanum tuberosum L. var. Vitelotte 31
Design, synthesis, and biological evaluation of 2-aminobenzanilide derivatives as potent and selective HDAC inhibitors. 30
Glycolytic heterogeneity drives metabolic-targeted therapy in pancreatic ductal adenocarcinoma 30
The Jumonji family: Past, present and future of histone demethylases in cancer 29
Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activity 28
Identification of NuRSERY, a new functional HDAC complex composed by HDAC5, GATA1, EKLF and pERK present in human erythroid cells 28
Sirtuins and disease: the road ahead 28
Quinoline-Based p300 Histone Acetyltransferase Inhibitors with Pro-apoptotic Activity in Human Leukemia U937 Cells 27
Epigenetic-based therapy: From single- to multi-target approaches 27
New synthetic approach to paullones and characterization of their SIRT1 inhibitory activity 27
1,3,4-Oxadiazole-Containing Histone Deacetylase Inhibitors: Anticancer Activities in Cancer Cells 26
Targeting Histone Deacetylases in Diseases: Where Are We? 26
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia 25
BLUEPRINT to decode the epigenetic signature written in blood. 25
Psidium guajava L. anti-neoplastic effects: induction of apoptosis and cell differentiation 24
Indole-Derived Psammaplin A Analogues as Epigenetic Modulators with Multiple Inhibitory Activities. 24
Context-Selective Death of Acute Myeloid Leukemia Cells Triggered by the Novel Hybrid Retinoid-HDAC Inhibitor MC2392 24
UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression. 24
Up-regulation of miR-146b and down-regulation of miR-200b contribute to the cytotoxic effect of Histone deacetylase inhibitors on ras-transformed thyroid cells. 24
tert-Butylcarbamate-Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells. 24
Targeting Histone Deacetylases in Diseases: Where Are We? 23
Whole-Genome Bisulfite Sequencing of Two Distinct Interconvertible DNA Methylomes of Mouse Embryonic Stem Cells. 23
Molecular pathways: the complexity of the epigenome in cancer and recent clinical advances. 23
Synthetic approaches to DNMT inhibitor SGI-1027 and effects on the U937 leukemia cell line. 23
Tumour cell population growth inhibition and cell death induction of functionalized 6-aminoquinolone derivatives 23
Glycation of Wild-Type Apomyoglobin Induces Formation of Highly Cytotoxic Species. 23
Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues. 23
HDAC modulation and cell death in the clinic 22
Natural compounds in epigenetics: A current view 22
Genista sessilifolia DC. extracts induce apoptosis across a range of cancer cell lines. 21
Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells. 20
Cardiomyogenesis is controlled by the miR-99a/let-7c cluster and epigenetic modifications 19
Chromatin accessibility, p300, and histone acetylation define PML-RAR? and AML1-ETO binding sites in acute myeloid leukemia. 18
Totale 2.463
Categoria #
all - tutte 9.081
article - articoli 8.880
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.961


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202425 0 0 0 0 0 0 0 0 0 2 17 6
2024/2025934 5 3 57 37 248 38 22 30 33 28 229 204
2025/20261.374 73 127 127 211 264 44 228 71 76 80 46 27
2026/2027130 124 6 0 0 0 0 0 0 0 0 0 0
Totale 2.463